Journal of Health and Medical Sciences
Published: 11 October 2021
Clinical Review and Management of Oral Potentially Malignant Disorders with Epithelial Dysplasia
Mustafa Mohammed Abdulhussain, Ali Sami Muhsin
Mustansiriyah University, Iraq
Download Full-Text Pdf
Keywords: Malignant Lesions, Premalignancy, Epithelial Dysplasia, Carcinoma, Risk Factors
Background: Oral potentially malignant disorders (OPMDs) comprise any disorders, tumors, in addition to any microscopic alterations that have a risk of malignant development of cancers of the mouth. When epithelial dysplasia is detected in an oral lesion, it is termed as a precancerous lesion. Finding: Several changes in the color or thickness of normal oral mucosa might be detected during the clinical diagnosis of the oral lesions. Leukoplakia of the oral cavity is a clinical name for one of the most predominant OPMDs of the oral mucosa. When comparing oral examination with naked eyes to planning to apply staining with special stain or using an image of optical fluorescence, the incidence of patients with oral epithelial dysplasia may rise, as well as the clearing of the lesion boundary. Increased size of more than 2cm2, the presence of colored regions with a red hue, the presence of lichenoid process characteristics, and severe epithelial dysplasia are all considered risk factors. One-third of premalignant lesions may progress to cancer, whereas the other two-thirds may stay stable or regress without progressing to malignancy. Conclusion: It is critical to research the patients' unique characteristics, which include psychological, genetic, dietary, and dental problems. When epithelial dysplasia is present in an oral lesion, it is termed a precancerous lesion. Oral potential malignant diseases with epithelial dysplasia may or may not develop into carcinoma and may or may not be recurrent.
Arduino PG, Surace A, and Carbone M, et al. Outcome of oral dysplasia: a retrospective hospital based study of 207 patients with a long follow-up. J Oral Pathol Med. 2009; 38(6):540‐544.
Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa-Diagnostic problems and prognostic features. Current Diagnostic Pathology 2006; 12:11–21.
Chainani-Wu N, Epstein J, Touger-Decker R. Diet and prevention of oral cancer: strategies for clinical practice. J Am Dent Assoc 2011 Feb; 142:166–9.
Cowan C, Gregg T, Napier S, McKenna S, Kee F. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001; 7(1):18‐24.
Dost F, Lê Cao K, Ford PJ, Ades C, Farah CS. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117(3):343‐352.
Edwards PC. The natural history of oral epithelial dysplasia: perspective on Dost et al. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117:263–6.
Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein M, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc 2007; 138:1555–62.
Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, et al. Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer 2009; 23(8):50.
Gong Y, Wei B, Yu L, Pan W. Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: a meta-analysis of observational studies. Oral Oncol 2015; 51:332–40.
Gorsky M, Epstein JB. Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111:461–4.
Güneri P, Cankaya H, Yavuzer A, Güneri EA, Erişen L, Ozkul D, et al. Primary oral cancer in a Turkish population sample: association with sociodemographic features, smoking, alcohol, diet and dentition. Oral Oncol 2005; 41:1005–12.
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99:777–89.
Hirai H, Tomioka H, Mochizuki Y, Oikawa Y, Tsushima F, Harada H. Clinical course of oral squamous cell carcinoma in patients on immunosuppressant and glucocorticoid therapy. J Oral Maxillofac Surg 2017; 75:1980–6.
Ho MW, Risk JM, Woolgar JA, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012; 48(10):969‐976.
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006; 42(5):461‐474.
Holmstrup PP, Vedtofte PP, and Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 2007; 36:262–6.
Jeong W-J, Paik JH, Cho S-W, Sung M-W, Kim KH, Ahn S-H. Excisional biopsy for management of lateral tongue leukoplakia: Management of lateral tongue leukoplakia. J Oral Pathol Med. 2012; 41(5):384‐388.
Khanal S, Shumway BS, Zahin M, Redman RA, Strickley JD, Trainor PJ, et al. Viral DNA integration and methylation of human papillomavirus type 16 in high-grade oral epithelial dysplasia and head and neck squamous cell carcinoma. Oncotarget 2018; 9:30419–33.
Liu W, Shi L-J, Wu L, et al. Oral cancer development in patients with leukoplakia—clinicopathological factors affecting outcome. PLoS One. 2012; 7(4):e34773.
Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow up of oral dysplasia-a Systematic review and meta-analysis. Head Neck. 2009; 31(12):1600‐1609.
Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med 2018; 47:633–40.
Mogedas-Vegara A, Hueto-Madrid JA, Chimenos-Küstner E, Bescós-Atín C. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients. J Craniomaxillofac Surg 2015; 43:677–81.
Raj AT, Kheur S, Gupta AA, Patil VR, Kharat A. The need for combination immunotherapy in oncology. Oral Oncol. 2019. https://doi.org/10.1016/j.oraloncology.2019.02.013. Feb 18. pii: S1368-8375(19)30049-1.
Rosenquist K, Wennerberg J, Schildt EB, Bladström A. Göran Hansson B, Andersson G. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125:1327–36.
Sano Y, Kogashiwa Y, Araki R, Enoki Y, Ikeda T, Yoda T, et al. Correlation of inflammatory markers, survival, and COX2 expression in oral cancer and implications for prognosis. Otolaryngol Head Neck Surg 2018; 1. 194599817745284.
Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer. 2000; 82(11):1871‐1874.
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125:612–27.
Speight PM. Update on oral epithelial dysplasia and progression to cancer. Head and Neck Pathol. 2007; 1(1):61‐66.
Sun Y, Liu N, Guan X, Wu H, Sun Z, Zeng H. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma. Mediators Inflamm 2016; 5715719.
Van der Waal I. potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009; 45(4-5):317‐323.
Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health 2014; 5(14):99.
Warnakulasuriya S, Kovacevic T, Madden P, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England: Malignant transformation in OPMD. J Oral Pathol Med. 2011; 40(9):677‐683.
Zamoiski RD, Yanik E, Gibson TM, Cahoon EK, Madeleine MM, Lynch CF, et al. Risk of second malignancies in solid organ transplant recipients who develop keratinocyte cancers. Cancer Res 2017; 77:4196–203.
Zhang L, Lubpairee T, Laronde DM, Rosin MP. Should severe epithelial dysplasia be treated? Oral Oncol 2016; 60:125–9.
Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, et al. Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila) 2012